Clinical Trial Update: A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating RP-3500 in combination with standard radiation therapy for solid tumors, including metastatic cancer, is active but not cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumor

Drugs mentioned

• RP-3500

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Solid Tumor, Metastatic Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING